Leading Healthcare & Biotech Hedge Funds surge 64% quarter-over-quarter, powered by Newcomers

September 21st, 2014
| More
The most recent Top 50 Healthcare, Pharmaceutical and Biotechnology Focused Hedge Fund list has been released, revealing that the top hedge funds now manage $129 billion in U.S. equity assets, having seen their asset jump by 64% quarter-over-quarter.

Leading the equity asset surge are a couple of very large newcomers to the list, Viking Global Investors and Pershing Square Capital Management. While Viking Global and Pershing Square do not typically focus on any particular sector, the two hedge funds have shifted a greater percentage of their portfolios into healthcare, pharma and biotech stocks, eclipsing the 35% portfolio threshold.

Viking Global claimed the top spot on the Top 50 Healthcare, Pharmaceutical and Biotechnology Hedge Fund List, stealing it away from Larry Robbins’ Glenview Capital Management.

Glenview Capital fell to #2 on the list, with $17.2 billion in equity assets under management. Glenview Capital’s sector favorites once again include Thermo Fisher Scientific (TMO), HCA Holdings Inc (HCA) and Tenet Healthcare Corp (THC).

Over the quarter, Glenview Capital purchased 1,381,300 shares of THC, increasing its position to more than 3% of the analytical instruments and laboratory equipment company’s shares outstanding. THC is also a notable favorite of the top long-term performing Healthcare, Pharma & Biotech Hedge Funds.

Other top investors that lead the Top Healthcare, Pharma and Biotech Hedge Fund List include #3 Pershing Square Capital and #4 OrbiMed Advisors.

The largest investments for OrbiMed Advisors, which is run by Samuel Isaly, include Intercept Inc (ICPT), Bristol-Myers Squibb (BMY), Biogen Idec Inc (BIIB) and Abbvie Inc (ABBV). Over the quarter, OribMed’s biggest sector buys were 1,222,600 shares of BMY and 1,283,600 shares of Celgene Corp (CELG)

Ranking Methodology: The Top Healthcare, Pharmaceutical and Biotechnology Hedge Fund rankings are compiled on a quarterly basis using hedge fund firms’ overall U.S. equity assets under management. The list includes the top hedge funds that have more than 35% of their U.S. equity assets invested in U.S. listed Healthcare, Pharma & Biotech companies. To view the Top Healthcare, Pharma & Biotech Hedge Fund list in its entirety, please visit HedgeTracker’s Hedge Fund Portal.
For Detailed Investor Profiles on these Investors, click below:
Galena Asset Management
Glenview Capital Management
OrbiMed Advisors
Pershing Square Capital Management
Viking Global Investors
Related People: Andreas Halvorsen; Brian Olson*; Claude Lixi; David Ott; Duncan Letchford; Frederic Codet; Jeremy Weir; Larry Robbins; Mark Newson-Smith; Mark Newson-Smith; Nicholas Botta; Roy J. Katzovicz; Samuel Isaly; Scott Ferguson*; William 'Bill' Ackman
Related Entities: Caduceus Asia Partners LP; Caduceus Capital LP; Eaton Vance Worldwide Health Sciences; Finsbury Worldwide Pharmaceutical; Galena Azurite Fund; Galena Energy Fund; Galena Malachite Fund; Galena Metals Fund; Galena Special Situations Fund; GCM Little Arbor Institutional Partners; GCM Little Arbor Master; GCM Little Arbor Partners; Glenview Capital Master; Glenview Capital Partners; Glenview Institutional Partners; Leucadia Corporation (NYSE: LUK); OrbiMed Associates; OrbiMed Capital; Pershing Square Capital; Pershing Square IV; Pershing Square LP; Tiger Management*; Trafigura Group; Viking Global Equities; Viking Global Equities III; Viking Global Investors LP
Related Article Tags: Multi-Strategy, Long Short, Equity, Debt and Global Macro Hedge Fund News; Top Hedge Fund Portfolio Reports


More Recent Headlines

Top performing TMT Hedge Funds agree on two things: Comcast and Netflix

12.3% YTD growth for largest Technology, Media & Telecom hedge funds; Lone Pine and Coatue Capital claim top spots

TFS Capital Remains Relevant Amid New Competition, Changing Market Conditions

Billions flow to Och-Ziff Capital Management Group, Despite sub-par Performance & bad press

Assets jump by nearly 18% for leading Emerging Hedge Fund Managers; Soroban Capital, Corvex Management & Roystone Capital power gains

Top Mid-Sized Hedge Fund List Revealed; Newbrook Capital Advisors and Decade Capital Management claim top spots

Blackstone Group ramps up hiring for big launch of the Blackstone Senfina Advisors hedge fund

California Hedge Funds continue to thrive, Assets surge by 13.5 percent

SAC’s Point72 Asset Management loses Thomas Conheeney; Gabriel Plotkin to launch Melvin Capital

“Best Ideas” hedge fund launched by Soroban Capital Partners